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and blocks nuclear pore dilation
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e tested the hypothesis that gp210, an integral
membrane protein of nuclear pore complexes
(NPCs), mediates nuclear pore formation. Gp210
has a large lumenal domain and small COOH-terminal tail
exposed to the cytoplasm. We studied the exposed tail. We
added recombinant tail polypeptides to 
 
Xenopus
 
 nuclear
assembly extracts, or inhibited endogenous gp210 tails using
anti-tail antibodies. Both strategies had no effect on the
formation of fused ﬂattened nuclear membranes, but
blocked NPC assembly and nuclear growth. Inhibited
nuclei accumulated gp210 and some nucleoporin p62, but
W
 
failed to incorporate nup214/CAN, nup153, or nup98 and
were defective for nuclear import of lamin B3. Scanning
and transmission EM revealed a lack of “closely apposed”
inner and outer membranes, and the accumulation of novel
arrested structures including “mini-pores.” We conclude that
gp210 has early roles in nuclear pore formation, and that
pore dilation is mediated by gp210 and its tail-binding
partner(s). We propose that membrane fusion and pore
dilation are coupled, acting as a mechanism to control
nuclear pore size.
 
Introduction
 
The eukaryotic genome is enclosed by two nuclear mem-
branes. A mechanism for fusion between the inner and outer
membranes to generate pores is essential for the genome to
communicate with the cytoplasm; indeed, the evolution of
eukaryotic organisms probably depended on a “porogenic”
fusion mechanism. Assembling pores have diameters that
range from 6–40 nm (Goldberg et al., 1997). In vertebrates,
mature pores have a diameter of 
 
 
 
50–70 nm and are occu-
pied by nuclear pore complexes (NPCs),* which regulate
molecular traffic between the nucleoplasm and cytoplasm
(Bayliss et al., 2000; Wente, 2000; Yoneda, 2000). Verte-
brate NPCs have a maximum mass of 125 MD (Reichelt et
al., 1990; Panté and Aebi, 1994) and consist of multiple
copies of 
 
 
 
40 distinct proteins (Miller and Forbes, 2000),
termed nucleoporins. NPCs are anchored at the pore mem-
brane domain, where the inner and outer membranes merge.
Soluble nucleoporins are recruited to the pore membrane
during NPC assembly. Pore formation was proposed to be
triggered by the binding of soluble proteins to membranes
(Fabergé, 1974) or by chromatin-induced indentations of
the inner nuclear membrane, as seen by transmission EM
(TEM; Maul et al., 1971). A role for chromatin in the forma-
tion of mature functional NPCs is likely, even though chro-
matin is not essential for porogenic membrane fusion per se
(Maul, 1977; Vasu and Forbes, 2001). Unidentified soluble
nucleoporins are required to stimulate pore formation in re-
gions of flattened nuclear membranes (Macaulay and Forbes,
1996), and also in ER-like membranes known as annulate
lamellae, which lack chromatin (Dabauvalle et al., 1991;
Meier et al., 1995). Along with most aspects of NPC assembly,
the mechanism of porogenic membrane fusion is an important
open question in biology.
 
Membrane fusion is central to secretion, endocytosis, and
the biogenesis of the ER, Golgi apparatus, and mitochondria
(Bennet and Scheller, 1993). These fusions are mediated by
cytosolic proteins that first disrupt the cytosolic leaflet of each
bilayer (Robinson and Martin, 1998). In contrast, nuclear
pore fusion involves the lumenal leaflets of the nuclear inner
and outer membranes, and therefore probably involves pro-
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teins within the lumenal space. Viral fusogens, such as hemag-
glutinin (HA) protein of influenza virus (Skehel and Wiley,
2000), are viewed as possible models for lumenal membrane
fusion events in normal cells. At low pH, membrane-embed-
ded HA trimers undergo a conformational change that exposes
their fusogenic peptides, allowing them to destabilize the op-
posing lipid bilayer and sequentially trigger membrane hemi-
fusion, pore formation, and pore dilation (Hernandez et al.,
1996; Kozerski et al., 2000). A conceptually different possibil-
ity is that soluble nucleoporins might assemble on the chroma-
tin surface and then recruit surrounding membranes laterally
as membranes attach to chromatin during nuclear assembly.
However, this hypothetical mechanism is restricted; it could
function only during the few minutes in telophase before
chromatin is enclosed by membranes, it cannot explain pore
formation during G1, S, or G2 phases of the vertebrate cell cy-
cle, nor explain pore formation in eukaryotes (e.g., 
 
Saccharo-
myces cerevisiae
 
) whose nuclei remain intact during mitosis.
Wozniak et al. (1989) and Greber et al. (1990) proposed
that nuclear pore formation might be mediated by gp210, an
integral membrane protein found at pores (Gerace et al.,
1982). Gp210 is linked structurally to NPCs, as antibodies
that target lumenal epitopes of gp210 decrease both active and
passive transport through NPCs (Greber and Gerace, 1992).
The majority of gp210 (95% of its mass) lies within the nu-
clear envelope lumen, but its short COOH-terminal tail is ex-
posed to the cytosol (Greber et al., 1990). This cytoplasmic
tail is specifically phosphorylated during mitosis, presumably
to facilitate NPC disassembly (Favreau et al., 1996). Circum-
stantial evidence for gp210 as a fusogen came from topologi-
cal studies. Rat gp210 was predicted by hydropathy analysis to
have two membrane spanning domains (Wozniak and Blobel,
1992). However, topological studies showed that only one,
the COOH-terminal hydrophobic domain, actually spans the
membrane, whereas the other sits in the lumenal domain
(Greber et al., 1990). Wozniak and Blobel (1992) suggested
that this “extra” hydrophobic domain might destabilize lipid
bilayers, triggering fusion. Also analogous to HA, which forms
trimers, gp210 was calculated to form dimers or trimers (Ger-
ace et al., 1982). Recent cross-linking studies show that gp210
forms stable dimers (Favreau et al., 2001).
By indirect immunofluorescence, many soluble nucle-
oporins reaccumulate rapidly at assembling nuclear enve-
lopes (Chaudhary and Courvalin, 1993; Bodoor et al., 1999;
Haraguchi et al., 2000). In contrast, gp210 is detectable at
early stages of nuclear assembly, but most gp210 does not
reaccumulate until late telophase or early G1 (Chaudhary
and Courvalin, 1993; Bodoor et al., 1999). Note that gp210
is not excluded from nuclei at early stages of assembly;
rather, it simply reaccumulates slowly, raising questions
about its theoretical early role in pore formation. The only
other known integral membrane nucleoporin in vertebrates,
POM121, accumulates rapidly during nuclear assembly
(Bodoor et al., 1999; Daigle et al., 2001). POM121 has a
large exposed domain and a small lumenal domain (Soder-
qvist and Hallberg, 1994). Overexpression of POM121 in
mammalian cells causes NPCs to form and accumulate in
ER membranes, suggesting direct or indirect roles in trigger-
ing NPC formation (Imreh and Hallberg, 2000). In yeast,
overexpression of a soluble nucleoporin named nup53,
which has an amphipathic 
 
 
 
-helix, induces the formation of
nuclear inner membrane tubules with empty pores (Marelli
et al., 2001).
We used 
 
Xenopus
 
 extracts to directly test the role of gp210,
if any, in pore formation. 
 
Xenopus
 
 egg extracts are a powerful
and well-characterized system for studying nuclear pore forma-
tion (Miller and Forbes, 2000; Vasu and Forbes, 2001). We
focused on the small exposed tail of gp210, because it is freely
accessible to reagents added to cell-free extracts. We found that
a recombinant gp210 tail polypeptide and antibodies against
the exposed COOH-terminal tail of 
 
Xenopus
 
 gp210 both in-
hibited pore formation. The arrest morphologies suggest an
unanticipated direct function for the gp210 tail and its bind-
ing partners in the dilation of nascent nuclear pores.
 
Results
 
To study gp210 function in the 
 
Xenopus
 
 system, we first had
to identify 
 
Xenopus
 
 gp210. We identified a partial cDNA
corresponding to the COOH terminus of 
 
Xenopus
 
 gp210 by
using the rat gp210 sequence to search the 
 
Xenopus
 
 EST da-
tabase (see Materials and methods; this EST clone had a mu-
tation). We then generated the corresponding wild-type
PCR product from a 
 
Xenopus
 
 oocyte cDNA library. This
partial cDNA encoded a polypeptide of 251 residues that
was 39% identical and 47% similar to the COOH-terminal
Figure 1. Partial Xenopus gp210 sequence and purification and testing of gp210 tail polypeptide. (A) Sequence alignment of rat gp210 
(residues 1636–1886) and the 251-residue polypeptide encoded by the partial Xenopus cDNA. The transmembrane domain (TMD) and the 
16-residue peptide (antigen) used to generate rabbit serum 3860 are underlined. Also indicated is the tail polypeptide of Xenopus gp210 that 
was recombinantly expressed, purified, and used to inhibit nuclear assembly. (B) SDS-PAGE gel showing the GST–gp210 tail fusion protein 
before (GST:tail) and after (GST, tail) cleavage by thrombin (see Materials and methods). (C) Effects of purified gp210 tail on nuclear assembly 
in Xenopus egg extracts. Purified gp210 tail was added to nuclear assembly reactions (final concentrations indicated) at time zero. 2 h later, 
nuclei were visualized by phase contrast microscopy and Hoescht staining for DNA. Bar, 10  m. 
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251 residues of rat gp210 (Fig. 1 A). As shown below, anti-
bodies against the COOH terminus confirmed that this
cDNA encoded gp210.
 
Recombinant gp210 tail polypeptide 
inhibits nuclear growth
 
We hypothesized that the function of gp210 may require in-
teractions between its cytoplasmic tail and other nucleopor-
ins. To test this hypothesis, we first expressed the 61-residue
gp210 tail as a 32.8-kD fusion protein with glutathione-
 
S
 
-transferase (GST), from which the 6.8-kD tail was purified
after cleavage by biotinylated thrombin (Fig. 1 B). The puri-
fied gp210 tail was added, at time zero, to nuclear assembly
reactions consisting of reconstituted 
 
Xenopus
 
 egg cytosol and
membranes plus demembranated sperm chromatin (Lohka
and Masui, 1984; Newmeyer and Wilson, 1991). Purified
gp210 tail was added to final concentrations ranging from 1
nM to 1 mM. Nuclei were allowed to assemble for 90 min
and then examined by light microscopy (Fig. 1 C). Nuclear
growth was fully inhibited by tail concentrations of 10 
 
 
 
M
or more. The growth-inhibited nuclei had phase-dense
membranes at the chromatin surface, but failed to expand or
decondense the chromatin. Inhibition by exogenous gp210
tails was specific, because control nuclei assembled in the
presence of an unrelated polypeptide (thrombin-cleaved, pu-
rified 10 
 
 
 
M GST) assembled and grew normally (unpub-
lished data). Further experiments were done using the tail
polypeptide at 10 
 
 
 
M, the lowest concentration tested that
terminally arrested nuclear envelope growth. This repre-
sented a fivefold excess over endogenous gp210 (
 
 
 
2 
 
 
 
M),
as estimated from densitometry analysis of immunoblots of
 
Xenopus
 
 membrane proteins and known concentrations of
the recombinant 
 
Xenopus
 
 gp210 tail (unpublished data).
To determine the time course of inhibition, reactions were
supplemented at time zero with 10 
 
 
 
M gp210 tail (or buffer
control) and imaged after 5, 10, 20, 30, 60, and 90 min of
assembly (Fig. 2 A). Membrane recruitment to the chroma-
tin surface was neither delayed nor inhibited by exogenous
gp210 tails. However, defects in nuclear growth and chro-
matin decondensation were obvious within 20–30 min,
 
when buffer addition control nuclei became fully enclosed
by a nuclear envelope and began enlarging. Nuclear growth
requires functional NPCs and active nucleocytoplasmic
transport (Macaulay and Forbes, 1996; Wiese et al., 1997).
The growth arrest caused by exogenous gp210 tails sug-
gested defects in NPC assembly or function.
 
Gp210 tail-inhibited nuclei fail to incorporate 
nucleoporins and lack lamin B3
 
To determine if tail-inhibited nuclei were defective for NPC
assembly or nuclear import, we tested the incorporation of
FG-repeat nucleoporins using mAb 414, and tested the accu-
mulation of lamin B3, which depends on signal-mediated
nuclear import (Loewinger and McKeon, 1988; Meier et al.,
1991; Firmbach-Kraft and Stick, 1995). Aliquots were re-
moved from assembly reactions after incubating for 5, 10,
20, 30, 60, and 90 min, and the nuclei were purified (see
Materials and methods), resolved by SDS-PAGE, blotted,
and probed for either nucleoporins (Fig. 2 B) or lamin B3
(Fig. 2 C) using mAb 414 and mAb S49F, respectively. The
corresponding control and inhibited samples were processed
for Western blotting in pairs so that the signals were directly
comparable in qualitative terms. As a further control, blots
were stripped and reprobed with an antibody that recognizes
nuclear membrane LAP2 proteins (Fig. 2, B and C, bottom),
or an antibody against 
 
Xenopus
 
 gp210 (Fig. 2 C, bottom; this
antibody is described below). These experiments confirmed
that nuclear membranes were recruited to chromatin. Several
isoforms of LAP2 were detected, as expected (Gant et al.,
1999). The reduced signals for both LAP2 and gp210 in in-
hibited nuclei were consistent with their smaller surface ar-
eas. Interestingly, the gp210 blots showed that gp210 accu-
mulated over time in both the control and inhibited nuclei
(Fig. 2 C), demonstrating that gp210 can accumulate in nu-
clei that lack at least a subset of soluble nucleoporins.
mAb 414 recognizes five nucleoporins (nup358, nup214/
CAN, nup153, nup98, and p62), all of which carry the
 
O
 
-linked 
 
N
 
-acetylglucosamine modification (Davis and Blobel,
1987; Aris and Blobel, 1989; Shah and Forbes, 1998).
Nup358 was not detected by mAb 414 in our Western blots,
Figure 2. Purified gp210 tail polypeptide 
inhibits nuclear growth and NPC 
assembly. (A) Time course of nuclear 
assembly in the presence of 10  M tail 
polypeptide. Nuclei were assembled in 
the presence (10  M) or absence (buffer 
control) of purified gp210 tail. Aliquots 
were removed at the times indicated and 
imaged by phase contrast microscopy to 
visualize nuclear membranes, and by 
fluorescence microscopy to visualize 
Hoescht-stained DNA. Bar, 10  m. 
(B and C) Western blot analysis of tail-
inhibited nuclei. Nuclei assembled in 
the presence of buffer or 10  M gp210 
tail were isolated after 5, 10, 20, 30, 
60, and 90 min of assembly, run on 
SDS-PAGE, blotted, and probed with (B) 
mAb 414 to identify incorporated FG 
repeat nucleoporins, and (C) mAb S49F to detect lamin B3. Each blot was stripped and reprobed with antibodies against Xenopus LAP2 to 
confirm recruitment of nuclear-specific membranes (bottom). The blots in (C) were lastly restripped and probed with antibodies against 
gp210 (bottom). Lanes marked LSS (low speed supernatant) were loaded with 1  l of crude Xenopus egg extract. 
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presumably because it failed to transfer under our conditions.
The other four nucleoporins accumulated rapidly over time in
the positive control nuclei (Fig. 2 B, buffer), as expected. The
tail-inhibited nuclei acquired p62, although not to control
levels (Fig. 2 B, gp210 tail). Tail-inhibited nuclei appeared to
be depleted of nup214, nup153, and nup98, despite near-
normal accumulation of gp210 in these nuclei (Fig. 2 C).
These results suggested that gp210 tail polypeptides selec-
tively blocked the recruitment of several soluble nucleoporins,
but not gp210 itself. Nup214 normally localizes to NPC cyto-
plasmic filaments (Kraemer et al., 1994), whereas nup153 and
nup98 localize to the NPC basket and proposed intranuclear
filaments (Sukegawa and Blobel, 1993; Radu et al., 1995;
Fontoura et al., 2001). Our conclusion that NPC assembly
was blocked in tail-inhibited nuclei was independently sup-
ported by the greatly reduced import of lamin B (Fig. 2 C).
To explain these defects, we hypothesized that our recombi-
nant tail polypeptides competed for putative tail-binding nu-
cleoporins, which could be either soluble or membrane associ-
ated. Our results thus implicate a putative gp210 tail–binding
nucleoporin(s) as having an early role in NPC assembly.
 
Antibodies to the gp210 tail also arrest nuclear growth
 
We raised rabbit polyclonal antibodies against the predicted
COOH-terminal 16 residues of 
 
Xenopus
 
 gp210 (Fig. 1 A, un-
derlined). This serum (no. 3860) was used to probe immuno-
blots of 
 
Xenopus
 
 egg membrane and cytosol fractions. The im-
mune antibodies specifically recognized a membrane protein
that migrated on SDS gels at 
 
 
 
195 kD (Fig. 3 A), similar to
the antigen recognized by a proposed anti-
 
Xenopus
 
 gp210
monoclonal antibody (Gajewski et al., 1996). Our 195-kD
antigen was undetectable in the cytosolic fraction, as expected
for an integral membrane protein. Recognition of the 195-kD
membrane protein was specifically competed by pretreating
serum 3860 with the peptide antigen (Fig. 3 A, 
 
 
 
). When
used for indirect immunofluorescence of cultured 
 
Xenopus
 
 ep-
ithelial (A6) cells, immune (but not preimmune) serum 3860
specifically stained the nuclear envelope in a punctate pattern
(Fig. 3 B, Xgp210) that colocalized with the family of FG re-
peat nucleoporins recognized by monoclonal antibody 414
(Fig. 3 B, nups). Punctate nuclear envelope staining was also
seen in nuclei assembled in 
 
Xenopus
 
 extracts (unpublished
data). The homology, appropriate antigen size on gels, mem-
brane cofractionation, and colocalization with NPCs at the
nuclear envelope all verified that clone AW642061 represents
 
Xenopus
 
 gp210, and further showed that our antibodies specif-
ically recognized 
 
Xenopus
 
 gp210.
To independently inhibit gp210 tail function, we assem-
bled nuclei in the presence of serum 3860 antibodies, which
were predicted to bind the COOH-terminal tip of the en-
dogenous gp210 tail. Immune or preimmune antibodies
were added at time zero to nuclear assembly reactions, and
assembly was monitored at different times by light micros-
copy (Fig. 4 A). Nuclei assembled in the presence of immune
antibodies successfully recruited membranes, but the chro-
Figure 3. Polyclonal anti–tail peptide serum 3860 recognizes a 
195-kD membrane protein that colocalizes with NPCs. (A) SDS-PAGE 
of Xenopus egg cytosol (cyto) and membrane (memb) proteins 
stained with Coomassie blue (C) or transferred to polyvinylidene 
difluoride membrane and probed with preimmune serum (P), 
immune serum (I), or peptide-blocked immune serum ( ). (B) 
Immunofluorescence of Xenopus A6 cells stained with Hoescht to 
localize DNA, mAb 414 to localize NPCs, and either preimmune 
(pre) or immune (im) serum 3860 against Xgp210. Bar, 10  m.
Figure 4. Antibodies to the gp210 tail inhibit nuclear growth. 
(A) Nuclei were assembled in the presence of immune or preimmune 
serum 3860 antibodies against the gp210 tail (see Materials and 
methods). Aliquots were removed at the times indicated, fixed, and 
visualized by phase contrast microscopy to show membranes and 
fluorescence microscopy to show Hoescht-stained DNA. Bar, 10 
 m. (B and C) Western blot analysis of antibody-inhibited nuclei. 
Nuclei assembled in the presence of preimmune or immune serum 
3860 were isolated after 5, 10, 20, 30, 60, and 90 min of incubation, 
run on SDS-PAGE, blotted, and probed with (B) mAb 414 to identify 
incorporated FG repeat nucleoporins and (C) mAb S49F to detect 
lamin B3. Each blot was stripped and reprobed with antibodies 
against Xenopus LAP2 to confirm the recruitment of nuclear-specific 
membranes (bottom). 
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matin failed to decondense and a block to nuclear envelope
growth was obvious by the 20-min time point (Fig. 4 A, Im).
By light microscopy, the arrested phenotype was indistin-
guishable from that caused by recombinant gp210 tails.
Nuclei assembled in the presence of preimmune or im-
mune antibodies were isolated, processed for SDS-PAGE,
and immunoblotted in pairs (control and inhibited) for the
incorporation of mAb 414–reactive nucleoporins and lamin
B3 (Fig. 4, B and C). Similar to tail-inhibited nuclei, the an-
tibody-inhibited nuclei incorporated detectable levels of only
one FG repeat nucleoporin, p62 (Fig. 4 B), and failed to ac-
cumulate lamin B3 (Fig. 4 C), consistent with an early arrest
of NPC assembly and lack of nuclear transport activity.
 
Tail- and antibody-inhibited nuclei are enclosed 
by flattened nuclear membranes
 
The above results suggest that exogenous tail peptides and
gp210 antibodies both arrested nuclear assembly at a very
early stage, with membranes attached to chromatin but no
functional pores. Nuclear pore formation and NPC assem-
bly can be assayed by scanning EM (SEM) as soon as patches
of nuclear membranes flatten onto the chromatin surface
(Wiese et al., 1997). In wild-type reactions, pores form asyn-
chronously and rapidly, and many mature NPCs are already
present by 
 
 
 
30 min, when chromatin becomes enclosed by
nuclear membranes (Wiese et al., 1997). To determine if
our inhibitors disrupted these cytosol-dependent membrane
fusion events, we imaged the inhibited and control nuclei
(assembled for 2 h) by SEM (see Materials and methods).
SEM visualization of control nuclei, assembled in the pres-
ence of buffer or preimmune serum, showed full-size nuclei
with fused and flattened nuclear envelopes and mature
NPCs, as expected (Fig. 5). Nuclei assembled with either
gp210 tail polypeptides or anti-tail antibodies were growth
arrested (Fig. 5, top), consistent with our light microscopy
results, and were all enclosed by flattened and fused mem-
branes, showing that nuclear vesicles fused normally. Impor-
tantly, these arrested nuclei lacked NPCs (Fig. 5; center and
bottom). However, tiny dimples or holes with diameters of
3–7 nm were visible on the surface of tail-inhibited nuclei
(Fig. 5, 
 
 
 
 tail, arrows in bottom panel). These tiny holes
were scarce in the antibody-arrested nuclei. We concluded
that our inhibitors arrested nuclear pore formation at two
distinct stages, with tail polypeptides arresting after the for-
mation of mini-pores. Antibodies against the gp210 tail ap-
peared to arrest pore formation at an earlier stage.
 
TEM reveals novel arrested intermediates 
in pore formation
 
We next used TEM to visualize the arrested nuclear mem-
branes in cross section (see Materials and methods). Positive
control nuclei assembled in the presence of buffer (Fig. 6 A)
or preimmune serum (Fig. 6 E) formed nuclear envelopes
with mature NPCs, as expected. The membranes surround-
ing a mature NPC are shown (tangential section) and traced
in Fig. 6, I and J. In contrast, nuclei arrested by the compet-
ing tail polypeptides (Fig. 6, B–D) or anti-gp210 antibodies
(Fig. 6, F–H) had striking, unprecedented morphologies:
the inner and outer membranes appeared to be fused at fre-
quent intervals, forming discrete electron-dense foci (Fig. 6,
B and F, arrows). In the mini-pores produced by exogenous
tail polypeptides, the two membranes were almost parallel
on an axis perpendicular to the nuclear envelope, and were
separated by a gap of 1–5 nm (Fig. 6, C and D). Tracings of
the membrane edge suggested that in two of three arrested
structures shown, membrane fusion might have been com-
pleted to yield a narrow (1–5 nm) pore (Fig. 6 D, white dot-
ted lines). Holes in this size range were barely detectable in
Figure 5. SEM of tail- and antibody-
inhibited nuclei coated with a 2.5-nm 
layer of chromium. Top row shows 
nuclei at low magnification to demon-
strate the growth arrest caused by 
exogenous gp210 tails and immune 
antiserum. (Left) Nuclei were assembled 
for 2 h in the presence of buffer (  buffer) 
or 10  M purified gp210 tail (  tail). 
Control nuclei were enclosed by 
flattened membranes with mature NPCs, 
best seen at higher magnification in the 
bottom. Nuclei assembled with 10  M 
gp210 tails were enclosed by fused and 
flattened nuclear membranes that lacked 
mature NPCs, but did have tiny pores 
(  tail, bottom, arrows). (Right) Nuclei 
were assembled with either preimmune 
(  preimmune) or immune (  immune) 
antisera against the gp210 tail. 
Preimmune-treated control nuclei had 
typical nuclear envelopes and NPCs 
(  preimmune, bottom). Nuclei 
assembled with immune antibodies 
were enclosed by flattened membranes 
that lacked any surface-detectable pore-
related structures. Scale bars (left) apply 
to each row. 
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the surface images shown in Fig. 5 (
 
 
 
 tail). We estimated
that the frequency of mini-pores was lower in the SEM im-
ages, probably due to masking of smaller pores by the 2.5-
nm layer of chromium.
Membranes arrested by anti-tail antibodies were pointy
rather than parallel, and we were unable to trace membranes
within the electron-dense gap (Fig. 6 H, white dotted lines).
Few, if any, mini-pores were detected in antibody-arrested
membranes by surface imaging (Fig. 5). Thus, exogenous
tails and anti-tail antibodies produced subtly different arrest
morphologies when viewed by TEM, independently sup-
porting our surface imaging results. Antibodies appeared to
inhibit either during or immediately after pore formation,
whereas tail polypeptides appeared to inhibit later, during
pore enlargement (dilation).
We next quantitated four definable morphological features
in the TEM images (Fig. 7 A). These features were dimples
(D), defined as short angular electron-dense indentations of
the outer membrane; twinned (T) membranes, defined as
 
 
 
40-nm paired indentations of the inner and outer mem-
branes (originally described by Maul et al., 1971); mature
NPCs (M); and both types of unusual arrested structures (A)
(only the pointy structure is shown in Fig. 7 A). We counted
these features, measured the total length (microns) of nuclear
envelope examined (Fig. 7 B), and graphed their frequencies
 
per micrometer of nuclear envelope (Fig. 7 C). This quantita-
tion showed that mature NPCs were largely absent from the
inhibited nuclei, strongly suggesting that gp210 is required for
NPC formation. Few, if any, (0–5%) arrested structures were
present in control nuclei, but comprised the majority (70%)
of structures seen in tail- or antibody-arrested nuclei (Fig. 7
B). The slightly higher frequency of total pore-related struc-
tures in the inhibited nuclei (Fig. 7 B, structures/micrometer)
suggested that these structures accumulated stably. Twinned
membranes were relatively abundant in control nuclei (34–
36% of total structures), but significantly reduced (to 2%)
in tail-inhibited nuclei and reduced by half (to 15%) in an-
tibody-inhibited nuclei. Similar structures, with closely-
apposed inner and outer membranes, were shown by Maul et al.
(1971) to be highly correlated with forming (or disassem-
bling) pores. Because twinned membranes were abundant in
our control nuclei, but missing or reduced in arrested nuclei,
we suggest that the gp210 tail and its partners might trigger
the close apposition of the inner and outer nuclear mem-
branes in addition to mediating pore dilation.
Finally, we considered the possibility that our inhibitors
might destabilize or revert mature NPCs, rather than (or in
addition to) blocking de novo pore assembly. To test this
model, we first preassembled nuclei for 90 min and then
added 10 
 
 
 
M tail polypeptides, gp210 antibodies, or the
Figure 6. TEM of tail- and antibody-inhibited 
nuclei. Nuclei were assembled for 2 h in the 
presence of (A) buffer alone or (B, C, and D) 10 
 M purified gp210 tail polypeptides. Control 
nuclei had decondensed chromatin enclosed 
within a typical flattened nuclear envelope with 
NPCs (arrows). Nuclear membranes assembled in 
the presence of 10  M gp210 tail (B–D) accumulated 
novel arrested structures (B, arrows) consistent 
with a late stage of fusion or arrested dilation of 
nascent pores. C shows an enlarged region of B, 
which is reproduced in D with dashed white lines 
tracing the inferred position of each membrane. 
Dotted white lines indicate ambiguities, including 
places where the plane of the lipid bilayer was not 
perpendicular to the TEM section; such “slanted” 
membranes appear to split into two lines. (E–H) 
Antibody inhibition. Nuclei were assembled in the 
presence of (E) preimmune or (F–H) immune serum 
3860 for 2 h. Positive control nuclei had typical 
nuclear envelopes with NPCs (E, arrows). Treatment 
with immune serum produced arrested electron-
dense structures (F, arrows). G and H show an 
enlargement of two arrested nascent pores, with 
dashed white lines in H tracing the inferred position 
of each membrane. (I and J) Tangential section 
through mature NPC, with membranes traced by 
dashed white lines in J. Bars: (A, B, E, and F) 200 
nm; (C, D, G, H, and J) 10 nm; (I) refer to bar in J. 
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corresponding controls. We imaged these reactions by SEM
immediately and 1 h later. The control and experimental
nuclei all remained intact with mature NPCs and were in-
distinguishable by SEM (see Fig. S1, available at http://
www.jcb.org/cgi/content/full/jcb.200108145/DC1), sug-
gesting that our reagents did not grossly disrupt the struc-
ture or function of mature NPCs.
 
Discussion
 
We report the effects of two independent reagents that tar-
geted the exposed cytosolic tail of gp210. Neither reagent af-
fected NPC morphology when added to assembled nuclei.
Importantly, neither reagent disrupted the membrane fusion
events required to generate flattened nuclear membranes.
However, when added to assembling nuclei, both reagents ef-
ficiently arrested nuclear pore formation at an early stage. To
explain the mechanisms of arrest, we propose that exogenous
tail polypeptides compete for tail-binding nucleoporins and
 
block their binding to endogenous gp210. We propose that
the anti-tail antibodies either cross-link endogenous gp210
tails and block their function sterically, or block their interac-
tions with tail-binding partners, or both. The antibodies
might arrest pore formation at a slightly earlier stage than ex-
ogenous/competing tail polypeptides. The antibody-arrested
structures were electron dense, and individual membranes
could not be traced, whereas polypeptide-inhibited mem-
branes appeared to form narrow mini-pores 1–5 nm in diam-
eter, which might permit limited diffusion. These tail-inhib-
ited nuclei accumulated lamin B3 to low levels, consistent
with (but not proving) the presence of narrow diffusion-com-
petent pores. Structures consistent with tiny pores (
 
 
 
3–7-
nm diameter) were also seen by surface imaging of tail-inhib-
ited nuclear membranes. Importantly, our inhibitors also
reduced the formation of closely-apposed twinned membranes,
proposed by Maul et al. (1971) to be precursors to pore for-
mation. These results strongly support our major conclusion
that gp210 has early roles in nuclear pore formation.
Antibodies inhibited pore formation more severely than
competing tails. When gp210 bound, these antibodies
might interfere sterically with neighboring proteins that
function independently of gp210. Alternatively, bound anti-
bodies might cluster gp210 or induce other conformational
changes that disrupt its lumenal domain. Antibodies that di-
rectly bind the lumenal domain of gp210 in vivo inhibit
both active transport and passive diffusion (Greber and Ger-
ace, 1992). We therefore speculate that our anti-tail anti-
bodies might also functionally disrupt the lumenal domain
of gp210.
Inhibitors have been useful to dissect the NPC assembly
pathway. Two inhibitors, GTP
 
 
 
S and NEM, block the
formation of fused, flattened membrane cisternae (Boman
et al., 1992; Newport and Dunphy, 1992; Macaulay and
Forbes, 1996). To study pore formation in vitro, one must
start with fused flattened membranes. The fusion of nuclear/
ER membranes involves the GTP-binding protein Ran
(Hetzer et al., 2000; Zhang and Clarke, 2000) and p97 ATP-
ase complexes (Hetzer et al., 2001). Nuclear membranes can
self-assemble as stacks of flattened cisternae in the absence of
chromatin (Dabauvalle et al., 1991; Meier et al., 1995).
Membrane fusion is delayed by a Ca
 
2
 
 
 
 buffer, BAPTA (Sul-
livan et al., 1993; Shumaker et al., 1998). BAPTA also com-
pletely blocks pore formation when added at time zero
(Macaulay and Forbes, 1996), or causes “star ring” interme-
diates to accumulate if added later in assembly (Goldberg
et al., 1997). Wheat germ agglutinin, a lectin that binds
 
O
 
-linked 
 
N
 
-acetylglucosamine–modified nucleoporins, also
blocks pore formation (Meier et al., 1995; Goldberg et al.,
1997). Our present findings add two novel intermediates
to the biochemically-defined pathway of pore formation.
BAPTA-arrested nuclei have flattened parallel poreless mem-
branes that lack FxFG repeat nucleoporins. In contrast, re-
agents that disrupt gp210 tail function appear to slow a pro-
posed membrane apposition event before fusion, but then
allow porogenic membrane fusion to initiate or progress to
the mini-pore stage. We propose that the BAPTA-arrested
and gp210 tail–arrested intermediates bracket the porogenic
fusion event, providing direct experimental access to the
mechanisms of pore formation and dilation.
Figure 7. Quantitation of pore-related nuclear membrane 
structures. We (A) identified and (B) quantitated four morphological 
features termed dimples, twinned membranes, mature NPCs, and 
arrested structures on TEM micrographs of arrested and control 
nuclei. Results are graphed in C as the average number of each 
feature per micron for nuclei arrested by 10  M gp210 tail (or 
buffer control), and for nuclei treated with preimmune (preimm) 
or immune (im) antibodies against the gp210 tail. For each positive 
control, the number (n) of individual nuclei from which these 
measurements were taken was 10; for tail polypeptide–inhibited 
nuclei, n   14; for antibody-arrested nuclei, n   15. 
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Nucleoporin p62 may be recruited 
early during porogenesis
 
Gp210-arrested nuclei accumulated p62, but failed to accu-
mulate nup214/CAN, nup98, or nup153. The p62 result
was probably not an artifact, because we gradient purified
our nuclei before running gels for Western blotting. There is
currently no evidence that p62 binds directly to the gp210
tail. Thus, p62 might be recruited to nascent pores indepen-
dent of gp210. The possible incorporation of p62 into
gp210 tail–arrested nuclei is intriguing, because p62 and its
binding partners form a ring structure (Macaulay and
Forbes, 1995; Hu et al., 1996) and are critical for transport
activity (Finlay et al., 1991).
 
Gp210 functions early in pore formation and its tail 
is involved in nuclear pore dilation
Our results suggest that interactions between the exposed
tail of gp210 and its putative binding partners might trigger
an important early event, namely the close apposition of in-
ner and outer nuclear membranes before fusion. Although
membrane fusion per se was not blocked, reagents that inter-
fered with the gp210 tail or its putative partners also caused
pore formation to arrest at two subsequent stages. For the
antibody-arrested stage, we could not determine if mem-
brane fusion was complete, due to the electron density of
these pointy structures. However the mini-pores that accu-
mulated in the presence of exogenous tail polypeptides ap-
pear to represent a normal intermediate in which the pore
has formed, but cannot dilate. Based on previous SEM stud-
ies, nascent pores are thought to progressively increase in di-
ameter from  1–5 nm (dimples) to  30–40 nm (stabiliz-
ing pores) and  50–70 nm (mature pores; Maul, 1977;
Goldberg et al., 1997). This model is supported by mini-
pores, which have diameters of 3–7 nm when visualized by
SEM and 1–5 nm when visualized by TEM. (Note that the
2.5-nm chromium coat on SEM samples would obscure
pores  3 nm in diameter). Thus, our findings suggest direct
roles for gp210 and its partners in triggering pore formation
and dilating nascent pores. We speculate that soluble tail-
binding nucleoporins play a positive role by forming spokes
or struts between gp210 tails, which insertionally expand the
size of the pore. Note that if tail-binding partners had inhib-
itory roles, pores would expand uncontrollably in the pres-
ence of competing gp210 tail polypeptides. We can there-
fore rule out inhibitory roles for tail-binding nucleoporins.
Pore dilation: a regulated event 
during nuclear pore formation?
Kozerski et al. (2000) proposed that the hydrophobicity of
the tail domain of influenza HA is crucial for pore dilation,
because dilation was blocked by a hydrophilic tail. The only
known function of the HA tail is passive: to exist, and not
interfere with fusion or pore dilation. Thus, the final diame-
ter of the pore may be irrelevant to a virus. Gp210 tails from
Xenopus, rat, and Caenorhabditis elegans also contain 30–
45% hydrophobic residues, although their positions are not
conserved. However, we conclude that the tail of gp210 is
not passive, because our results suggest that nuclear pore di-
lation is coupled to the assembly of soluble nucleoporins.
Without this link, NPCs might assemble incorrectly, or
worse, pores themselves might enlarge and fenestrate the nu-
clear envelope, destroying its integrity as a boundary. Our
results strongly suggest that the tail of gp210 plus one or
more unidentified tail-binding nucleoporins mediate the
close apposition of nuclear membranes, and nuclear pore di-
lation. Possible mechanisms to control pore dilation include
the oligomerization of gp210 lumenal domains into a grom-
met that encircles the pore membrane domain, or the assem-
bly of tail-binding struts, or both.
Nuclear membrane fusion and pore dilation could be cou-
pled efficiently if the same protein (or two interacting pro-
teins) mediated both events. Our results thus do not rule
out, and moreover support, the hypothesis that gp210 di-
rectly mediates porogenic membrane fusion (Wozniak et al.,
1989; Greber et al., 1990; Wozniak and Blobel, 1992).
However, our results restrict the still hypothetical, fusogenic
activity of gp210 to its highly-conserved lumenal domain
(Cohen et al., 2001). Testing these models for gp210 func-
tion will require determining the gp210-null phenotype and
identifying nucleoporins that bind its tail.
Materials and methods
Partial cDNA cloning of Xenopus gp210
We identified an 807-bp cDNA clone (AW642061) in the Blackshear/
Soares normalized database for Xenopus egg library ESTs and obtained the
EST clone from Research Genetics Inc. After sequencing this DNA, we
compared its predicted ORF for the gp210 tail with rat gp210. The pre-
dicted Xgp210 tail had 23 fewer amino acids, due to an extra nucleotide
that created a stop codon. To determine if this stop codon was a PCR arti-
fact in the EST clone, we did a PCR reaction from a stage I/II Xenopus oo-
cyte cDNA library (from A. Wolffe, National Institutes of Health, Bethesda,
MD) using primers 5 -TGTAAAACGACGGCCAGT-3  and 5 -CAGGAAA-
CAGCTATGACC-3 . This partial cDNA was subcloned into the pCRT7
TOPO TA vector (Invitrogen) to generate clone Xp-gp210, which was
DNA sequenced (unpublished data) and shown to lack the truncating mu-
tation. The longer amino acid sequence predicted by our clone, Xp-gp210,
is shown in Fig. 1.
Expression construct for GST–gp210 tail fusion
Different primers were used to generate a cDNA encoding only the cyto-
plasmic tail (COOH-terminal 61 residues) of Xenopus gp210 from the Xe-
nopus stage I/II oocyte DNA library noted above. These new primers
added BamH1 and Sma1 sites to the 5  and 3  regions of the gp210 tail,
respectively (sense primer, 5 -GGGGCAGCAATAACCGGATCCATTAT-
GTCA-3 ; antisense primer, 5 -ACCCCAAATCCCGGGACAACATCGTTG-
TAC-3 ). The PCR product and pGEX-2T vector (Amersham Pharmacia
Biotech) were both sequentially digested with BamH1 and Sma1, gel puri-
fied, and ligated together. Correct insertion of the Gp210 tail fragment into
pGEX-2T was verified by double-stranded DNA sequencing (unpublished
data). The resulting construct, named Xenopus tail (Xt)-gp210, was ex-
pressed in bacteria as a recombinant protein consisting of the gp210 tail
fused at its NH2 terminus to GST.
Protein expression and thrombin cleavage
The pGEX-2T vector containing the gp210 tail insert was transformed into
competent Escherichia coli cells (strain BL21 DE3 pLysS; Novagen, Inc.)
and grown in LB media containing 40  g/ml ampicillin and 36  g/ml
chloramphenicol to an OD600 of 0.5. Protein expression was induced for
3 h using 1 mM IPTG. Cells were pelleted and the fusion protein purified
by chromatography on glutathione-Sepharose according to manufacturer
specifications (Amersham Pharmacia Biotech). The purified fusion protein
was incubated with biotin-conjugated thrombin (Novagen, Inc.) for 4 h at
22–24 C. Biotinylated thrombin was removed by binding to streptavidin-
Sepharose (Novagen, Inc.). Isolated gp210 tail polypeptide was either used
fresh or stored in aliquots at –20 C.
Antibodies
A peptide corresponding to the predicted COOH-terminal 16 residues of
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verse phase HPLC with the use of a C18 analytical column, and conju-
gated to keyhole limpet hemocyanin by Boston Biomolecules. This peptide
was used to immunize rabbit 3860. mAb 414, which is specific for FG re-
peat nucleoporins, was from Covance Research Products. The mAb against
Xenopus lamin B3, 46F7, was the gift of Reimer Stick (Göttingen Univer-
sity, Göttingen, Germany). Rabbit serum 2806 was raised against recombi-
nant Xenopus LAP2 residues 1–165, comprising the “constant” region of
Xenopus LAP2 (Gant et al., 1999; Dechat et al., 2000). Rabbit serum pro-
duction was done by Covance Research Products.
Nuclear assembly reactions
Demembranated Xenopus sperm chromatin (used at 1,000 sperm/ l ex-
tract) was prepared as previously described (Newmeyer and Wilson, 1991)
and incubated at 22–24 C in reconstituted cell-free extracts of Xenopus
eggs supplemented with 2 mM ATP, 10 mM creatine phosphate, and 50
 g/ml creatine kinase (Hutchison et al., 1988). Assembly reactions were
then supplied with purified recombinant Xenopus gp210 tail, immune or
preimmune serum 3860, or an equal volume of wash buffer (50 mM
Hepes, pH 7.6, 50 mM KCl, 2.5 mM MgCl2, 1  g/ml leupeptin, 1  g/ml
aprotinin) as a control. These reagents contributed no more than 10% to
the final volume.
Isolation of nuclei assembled in vitro
To isolate in vitro–assembled nuclei, 50- l assembly reactions were di-
luted with 1 ml of ice-cold nuclear isolation buffer (NIB) (20 mM Tris-HCl,
pH 7.4, 70 mM KCl, 5 mM MgCl2, 2 mM DTT, 2% polyvinylpyrolidone).
Diluted reactions were pooled and layered over 60% Percoll (in NIB) and
centrifuged at 3,000 g for 10 min at 4 C. Material was collected from the
NIB–Percoll interface, supplemented with ice-cold NIB to a volume of 1
ml, layered over 0.5 ml of 25% sucrose (wt/vol in NIB), and centrifuged at
2,500 rpm in a benchtop microfuge to yield a nuclear pellet. The nuclear
pellet was resuspended in SDS sample buffer and boiled for 3 min. For
analysis by SDS-PAGE and Western blotting, the equivalent of 2   10
5 nu-
clei was loaded per lane, as confirmed by removing an aliquot and count-
ing the number of pelleted nuclei.
SDS-PAGE, immunoblotting, and densitometry
Proteins were resolved on precast 4–12% Bis-Tris polyacrylamide gels
(Novex) by electrophoresis at 200 V for 1 h, and then either stained with
Coomassie blue or transferred to a polyvinylidene difluoride membrane.
Immunoblots were probed with a 1:500 dilution of anti-gp210 tail serum
3860 in PBS-T (PBS containing 0.1% Tween-20). Alternatively, blots were
probed for 1 h at 22–24 C with (a) mAb 414 diluted to 1:5,000 with PBS-T
or (b) monoclonal antibody 46F7 at a 1:500 dilution to detect Xenopus
lamin B3. After three washes in PBS-T, blots were incubated for 1 h at 22–
24 C with 1:25,000 dilution of HRP-conjugated secondary antibodies
(anti–rabbit or anti–mouse; Pierce Chemical Co.). Membranes were
washed as before and visualized by ECL (Amersham Pharmacia Biotech).
To probe for LAP2, each blot was stripped by incubation with 15% H2O2
(in PBS) for 30 min at 22–24 C, washed for 15 min in PBS-T, incubated
with serum 2806 diluted 1:50,000, and processed as described above.
LAP2-probed blots were then restripped and blotted for gp210 as de-
scribed above.
Fluorescence microscopy
Aliquots of assembly reactions were diluted fourfold with Fix-Stain buffer
(15 mM Pipes, pH 7.2, 80 mM KCl, 5 mM EDTA, 15 mM NaCl, 3.3%
formaldehyde, and 10  g/ml Hoescht 33258). Samples were imaged on a
Nikon Microphot using a cooled CCD camera with UV filters to detect
DNA and phase contrast to visualize nuclear membranes. Xenopus A6
cells were cultured in a 60% solution of Leibovitz L15 media containing
10% FBS, MEM nonessential amino acid solution (1 ), penicillin, and
streptomycin (each at 0.1 mg/ml). Cells were fixed in PBS with 4% parafor-
maldehyde, and stained for indirect immunofluorescence using mAb 414
at 1:5,000, or serum 3860 at 1:100. Goat ant–rabbit secondary antibodies
were conjugated with either Cy3 or FITC and used at 1:500. DNA was
stained with Hoescht. Images were collected and processed using IPLab
Spectrum software.
Field emission SEM
A 4- l aliquot of each assembly reaction was diluted in 500  l buffer (150
mM sucrose, 50 mM KCl, 2.5 mM MgCl2, 50 mM Hepes, pH 8, 1 mM
DTT, 1  g/ml each of aprotinin and leupeptin) and sedimented at 3,000 g
for 10 min at 4 C onto acetone-washed silicon chips (Fred Pella). Chips
were incubated for at least 10 min in SEM fix buffer (150 mM sucrose, 50
mM KCl, 80 mM Pipes-KOH, pH 6.8, 1 mM MgCl2, 0.25% gluteraldehyde
(EM grade), 2% paraformaldehyde [Sigma-Aldrich]). Chips were then
washed in 0.2 M sodium cacodylate, pH 7.2, post-fixed for 10 min in 1%
OsO4 (in 0.2 M Na cacodylate, pH 7.2), washed in water, stained for 10
min in 1% uranyl acetate (in water), and dehydrated in a graded ethanol
series (30%, 50%, 70%, 95%, and two times at 100% ethanol, followed by
two times at 100% Arklone). Samples were then critical point dried from
high purity CO2 using Arklone (trichlorotrifluoroethane; ICI) as a transi-
tional solvent. Dried samples were sputter coated with a 2.5-nm coat of
chromium in an Edwards Auto 306 coating unit. Samples were viewed on
the top stage of an ABT dual stage SEM (DS-130F) (Topcon Corp.) at a 30-
kV accelerating voltage.
TEM
Nuclear assembly reactions (50  l) were diluted in 3% gluteraldehyde,
1.5% paraformaldehyde, 0.1 M sodium cacodylate, and 3 mM MgCl2 to a
final volume of 1 ml, and fixed for 1 h on ice. Nuclei were then pelleted in
a Beckman Coulter Microfuge E horizontal benchtop centrifuge for 1 min
at high speed at 4 C. Pellets were incubated on ice four times (10 min
each) with 0.1 M sodium cacodylate and 3 mM MgCl2, repelleted, and
then incubated with 2% osmium tetroxide (in 0.1 M sodium cacodylate
with 3 mM MgCl2) for 1 h on ice. Pellets were washed twice with water (5
min each), incubated in 2% aqueous uranyl acetate at 22–24 C, and then
dehydrated through a graded ethanol series (30, 50, 70, 95, 100%). After
three 10-min incubations in 100% ethanol, samples were embedded in
Spurrs, sectioned, and viewed on a Philips microscope at 60 kV.
Online supplemental material
Fig. S1 (available online at http://www.jcb.org/cgi/content/full/
jcb.200108145/DC1) shows that exogenous gp210 tail polypeptides and
anti-tail antibodies have no detectable effects on preformed NPCs. Nuclei
were preassembled for 90 min, treated for 1 h with buffer or 10  M tail
polypeptide, or immune or preimmune serum 3860, and imaged by SEM.
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